468 related articles for article (PubMed ID: 18625318)
21. CAG repeat instability in embryonic stem cells and derivative spermatogenic cells of transgenic Huntington's disease monkey.
Khampang S; Parnpai R; Mahikul W; Easley CA; Cho IK; Chan AWS
J Assist Reprod Genet; 2021 May; 38(5):1215-1229. PubMed ID: 33611676
[TBL] [Abstract][Full Text] [Related]
22. Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease.
Menalled L; Zanjani H; MacKenzie L; Koppel A; Carpenter E; Zeitlin S; Chesselet MF
Exp Neurol; 2000 Apr; 162(2):328-42. PubMed ID: 10739639
[TBL] [Abstract][Full Text] [Related]
23. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation.
Mangiarini L; Sathasivam K; Mahal A; Mott R; Seller M; Bates GP
Nat Genet; 1997 Feb; 15(2):197-200. PubMed ID: 9020849
[TBL] [Abstract][Full Text] [Related]
24. Cellular therapy and induced neuronal replacement for Huntington's disease.
Benraiss A; Goldman SA
Neurotherapeutics; 2011 Oct; 8(4):577-90. PubMed ID: 21971961
[TBL] [Abstract][Full Text] [Related]
25. Genetics and neuropathology of Huntington's disease.
Reiner A; Dragatsis I; Dietrich P
Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
[TBL] [Abstract][Full Text] [Related]
26. Lessons from animal models of Huntington's disease.
Rubinsztein DC
Trends Genet; 2002 Apr; 18(4):202-9. PubMed ID: 11932021
[TBL] [Abstract][Full Text] [Related]
27. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
28. Huntington's disease: translating a CAG repeat into a pathogenic mechanism.
MacDonald ME; Gusella JF
Curr Opin Neurobiol; 1996 Oct; 6(5):638-43. PubMed ID: 8937828
[TBL] [Abstract][Full Text] [Related]
29. Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.
Möncke-Buchner E; Reich S; Mücke M; Reuter M; Messer W; Wanker EE; Krüger DH
Nucleic Acids Res; 2002 Aug; 30(16):e83. PubMed ID: 12177311
[TBL] [Abstract][Full Text] [Related]
30. Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.
Castiglioni V; Onorati M; Rochon C; Cattaneo E
Neurobiol Dis; 2012 Apr; 46(1):30-40. PubMed ID: 22227000
[TBL] [Abstract][Full Text] [Related]
31. Molecular aspects of Huntington's disease.
Walling HW; Baldassare JJ; Westfall TC
J Neurosci Res; 1998 Nov; 54(3):301-8. PubMed ID: 9819135
[TBL] [Abstract][Full Text] [Related]
32. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
[TBL] [Abstract][Full Text] [Related]
33. Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances.
McQuade LR; Balachandran A; Scott HA; Khaira S; Baker MS; Schmidt U
J Proteome Res; 2014 Dec; 13(12):5648-59. PubMed ID: 25316320
[TBL] [Abstract][Full Text] [Related]
34. Quantification of age-dependent somatic CAG repeat instability in Hdh CAG knock-in mice reveals different expansion dynamics in striatum and liver.
Lee JM; Pinto RM; Gillis T; St Claire JC; Wheeler VC
PLoS One; 2011; 6(8):e23647. PubMed ID: 21897851
[TBL] [Abstract][Full Text] [Related]
35. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
Wang H; Lim PJ; Karbowski M; Monteiro MJ
Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
[TBL] [Abstract][Full Text] [Related]
36. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
37. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse.
Wheeler VC; Auerbach W; White JK; Srinidhi J; Auerbach A; Ryan A; Duyao MP; Vrbanac V; Weaver M; Gusella JF; Joyner AL; MacDonald ME
Hum Mol Genet; 1999 Jan; 8(1):115-22. PubMed ID: 9887339
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress causes DNA triplet expansion in Huntington's disease mouse embryonic stem cells.
Jonson I; Ougland R; Klungland A; Larsen E
Stem Cell Res; 2013 Nov; 11(3):1264-71. PubMed ID: 24041806
[TBL] [Abstract][Full Text] [Related]
39. Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis.
Nguyen GD; Gokhan S; Molero AE; Mehler MF
PLoS One; 2013; 8(5):e64368. PubMed ID: 23691206
[TBL] [Abstract][Full Text] [Related]
40. Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.
Jacquet L; Neueder A; Földes G; Karagiannis P; Hobbs C; Jolinon N; Mioulane M; Sakai T; Harding SE; Ilic D
PLoS One; 2015; 10(5):e0126860. PubMed ID: 25993131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
